ATCC to Use NJ Hospital Samples in Pancreatic Cancer Biomarker Hunt | GenomeWeb
NEW YORK (GenomeWeb News) - American Type Culture Collection will use certain genomic technologies to study pancreatic tissue samples collected at a New Jersey Hospital for biomolecules that can be used to help detect, monitor, and potentially treat pancreatic cancer, ATCC said Thursday.
 
ATCC’s platform consists of integrated genomics, proteomics, and bioinformatics technologies and “has already demonstrated effectiveness in uncovering novel biomarkers for type 2 diabetes,” the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.